# Evolution Weaknesses: LAB-015

**Experiment**: LAB-015 (Genome Evolution Validation)
**Date**: 2026-07-19
**Mode**: STRESS TESTING

---

## Overview

This document attempts to break the evolution model through stress testing scenarios. Documented weaknesses are categorized by severity and potential mitigation strategies.

---

## Weakness 1: Simultaneous Contradicting Evidence

### Description
Multiple contradicting evidence arrives simultaneously for the same gene.

### Scenario
```
LAB-015 produces:
- Evidence A: "Domain X achieves HIGH with 3 runs"
- Evidence B: "Domain X achieves MEDIUM with 3 runs"

Both contradict GENE-0006 (Confidence Thresholds).
```

### Impact
| Aspect | Effect |
|--------|--------|
| Confidence Calculation | Conflicting signals - which wins? |
| Classification | Unclear whether to promote or demote |
| Governance | Requires adjudication |

### Current Model Gap
The model does not specify:
- How to weight contradictory evidence
- Which contradiction "wins"
- How to handle simultaneous contradictory evidence

### Mitigation Strategy
```
1. Record both contradictions
2. Do not change confidence until resolved
3. Flag for Governance adjudication
4. Weight evidence by:
   - Source reliability
   - Experiment methodology quality
   - Temporal proximity to gene creation
```

### Severity: **MEDIUM**

### Recommendation
Add "Evidence Weighting Protocol" to evolution rules.

---

## Weakness 2: Multiple Experiments, One Gene

### Description
Multiple experiments affect the same gene simultaneously.

### Scenario
```
LAB-015: Strengthens GENE-0001
LAB-016: Strengthens GENE-0001
LAB-017: Partially contradicts GENE-0001

All three arrive in same evolution cycle.
```

### Impact
| Aspect | Effect |
|--------|--------|
| Gene Version | Multiple increments needed |
| Confidence | Net effect unclear |
| History | Multiple mutation entries |

### Current Model Gap
The model handles sequential evolution but not parallel evolution from multiple sources.

### Mitigation Strategy
```
1. Process evidence chronologically
2. Apply changes in order of arrival
3. Create separate mutation entries for each
4. Calculate net confidence effect
```

### Severity: **LOW**

### Recommendation
The model can handle this with sequential processing. Document the processing order.

---

## Weakness 3: Competing Gene Proposals

### Description
Two competing gene proposals emerge for the same concept.

### Scenario
```
Researcher A proposes GENE-0014A: "Automated tooling improves quality"
Researcher B proposes GENE-0014B: "Automated tooling introduces bias"

Both cannot coexist as valid genes.
```

### Impact
| Aspect | Effect |
|--------|--------|
| Gene Registry | Duplicate concept, different conclusions |
| Classification | Unclear which is valid |
| Governance | Competing proposals require resolution |

### Current Model Gap
The model does not specify:
- How to handle competing proposals
- Who adjudicates competing claims
- Whether both can exist

### Mitigation Strategy
```
1. Flag as "COMPETING_PROPOSAL"
2. Do not create either gene until resolved
3. Require evidence comparison
4. Governance decides which is supported
5. Rejected proposal marked as REJECTED
```

### Severity: **HIGH**

### Recommendation
Add "Competing Proposal Protocol" to evolution rules. Require Governance resolution before gene creation.

---

## Weakness 4: Circular Dependencies

### Description
Gene mutations create circular dependencies.

### Scenario
```
GENE-A refines GENE-B
GENE-B refines GENE-A

Circular: A → B → A
```

### Impact
| Aspect | Effect |
|--------|--------|
| Relationships | Infinite loop potential |
| Classification | Unclear hierarchy |
| Traceability | Circular path |

### Current Model Gap
The model does not prevent circular dependencies in predecessor/successor chains.

### Mitigation Strategy
```
1. Validate gene creation: no circular paths
2. Check predecessor/successor chains for cycles
3. Reject gene creation if cycle detected
4. Example validation:
   if GENE-B.predecessor == GENE-A:
       reject GENE-A.creation if GENE-B.predecessor == GENE-A
```

### Severity: **CRITICAL**

### Recommendation
Add circular dependency validation to gene creation protocol. Reject genes that would create cycles.

---

## Weakness 5: Retirement of Foundational Genes

### Description
A foundational STABLE_CORE gene becomes obsolete.

### Scenario
```
GENE-0001 (Traceability) becomes obsolete due to new paradigm:
- "Non-traceable evidence is sometimes valid"
- "Traceability is not always required"
```

### Impact
| Aspect | Effect |
|--------|--------|
| Relationship Graph | Child genes orphaned |
| GENE-0009 | Applicability boundary foundation affected |
| All genes | Trust in evidence reduced |

### Current Model Gap
The model allows any gene to be deprecated but does not address cascading effects.

### Mitigation Strategy
```
1. Require impact analysis before deprecation
2. Identify all dependent genes
3. Decide: deprecate together or restructure
4. Example:
   - If GENE-0001 deprecated:
     - Check GENE-0002, GENE-0003, GENE-0009
     - Option A: Deprecate all (major restructuring)
     - Option B: Keep core genes, deprecate specific claims
5. Governance approval required
```

### Severity: **CRITICAL**

### Recommendation
Add "Impact Analysis" requirement before deprecation of foundational genes. Define "foundational" status explicitly.

---

## Weakness 6: Schema Evolution

### Description
The Genome schema itself needs to evolve.

### Scenario
```
LAB-015 discovers: Gene needs a new field "Validation Method"

New field required: "validation_method"
```

### Impact
| Aspect | Effect |
|--------|--------|
| Schema Version | 1.0 → 2.0 |
| Existing Genes | Retroactive update or migration |
| Documentation | All genes need update |

### Current Model Gap
The model specifies version compatibility but not migration strategy.

### Mitigation Strategy
```
1. Version the schema: GENOME-SCHEMA-1.0, GENOME-SCHEMA-2.0
2. Genes reference schema version
3. Migration: scripts or manual update
4. Backward compatibility when possible
5. Major changes: new Genome version
```

### Severity: **MEDIUM**

### Recommendation
Define schema migration strategy. Genes should reference schema version.

---

## Weakness 7: Orphan Gene Accumulation

### Description
Genes accumulate but never get deprecated.

### Scenario
```
Over time:
- GENE-0006 superseded by GENE-0010
- GENE-0010 superseded by GENE-0020
- GENE-0020 superseded by GENE-0030
- GENE-0006, GENE-0010, GENE-0020 remain as historical records

Gene count grows indefinitely.
```

### Impact
| Aspect | Effect |
|--------|--------|
| Registry Size | Unlimited growth |
| Query Performance | Degrades over time |
| Maintenance | Harder to find current state |

### Current Model Gap
The model does not specify:
- When genes become "historical only"
- Archive criteria
- Cleanup or pruning

### Mitigation Strategy
```
1. Define "ARCHIVED" status for old genes
2. Archive genes after N successor generations
3. Archived genes: queryable but not prominent
4. Example:
   - GENE-0006: ARCHIVED (3 generations old)
   - GENE-0010: ACTIVE
   - GENE-0020: ACTIVE
```

### Severity: **LOW**

### Recommendation
Add "ARCHIVED" status to lifecycle. Archive genes after 3 successor generations.

---

## Weakness 8: Gene Split Cascade

### Description
Gene splits trigger cascade of related splits.

### Scenario
```
GENE-0008 splits into GENE-0011, GENE-0012, GENE-0013
GENE-0013 is related to GENE-0007
GENE-0007 now needs refinement
```

### Impact
| Aspect | Effect |
|--------|--------|
| Number of Mutations | Exponential growth |
| Relationship Graph | Complex interconnected web |
| Tracking | Hard to follow evolution |

### Current Model Gap
Gene splits can affect related genes but model doesn't specify cascade handling.

### Mitigation Strategy
```
1. Identify cascade effects before split
2. Process cascade in single mutation cycle
3. Document cascade dependencies
4. Example:
   - GENE-0008 split triggers:
     - GENE-0011 (new)
     - GENE-0012 (new)
     - GENE-0013 (new, related to GENE-0007)
     - GENE-0007 refinement (update)
```

### Severity: **MEDIUM**

### Recommendation
Add "Cascade Analysis" to gene split protocol. Process related changes together.

---

## Weakness Summary

| Weakness | Severity | Mitigation Available |
|----------|----------|---------------------|
| Simultaneous Contradictions | MEDIUM | YES |
| Multiple Experiments, One Gene | LOW | YES |
| Competing Proposals | HIGH | YES |
| Circular Dependencies | CRITICAL | YES |
| Retirement of Foundational | CRITICAL | YES |
| Schema Evolution | MEDIUM | YES |
| Orphan Accumulation | LOW | YES |
| Gene Split Cascade | MEDIUM | YES |

---

## Critical Weaknesses Requiring Immediate Action

### 1. Circular Dependencies
**Action**: Add validation to gene creation protocol.

### 2. Retirement of Foundational Genes
**Action**: Add impact analysis requirement and define "foundational" status.

### 3. Competing Proposals
**Action**: Add Competing Proposal Protocol with Governance resolution.

---

## Recommendations

1. **Add Evidence Weighting Protocol** - Handle simultaneous contradictions
2. **Add Circular Dependency Validation** - Prevent infinite loops
3. **Add Impact Analysis Requirement** - Before deprecation of foundational genes
4. **Add Competing Proposal Protocol** - Governance resolution for competing claims
5. **Define "Foundational" Status** - Explicit identification of critical genes
6. **Add ARCHIVED Status** - Manage gene count over time
7. **Add Cascade Analysis** - For gene splits
8. **Add Schema Migration Strategy** - For schema evolution

---

## Validation Result

**STRESS TEST**: 8 weaknesses identified, all mitigable.

The evolution model is fundamentally sound but requires additional protocols for edge cases.
